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Abstract
Background: The efficiency of lymph nodes depends on tissue structure and organization, which
allow the coordination of lymphocyte traffic. Despite their essential role, our understanding of
lymph node specific mechanisms is still incomplete and currently a topic of intense research.
Results:  In this paper, we present a hybrid discrete/continuous model of the lymph node,
accounting for differences in cell velocity and chemotactic response, influenced by the spatial
compartmentalization of the lymph node and the regulation of cells migration, encounter, and
antigen presentation during the inflammation process.
Conclusion: Our model reproduces the correct timing of an immune response, including the
observed time delay between duplication of T helper cells and duplication of B cells in response to
antigen exposure. Furthermore, we investigate the consequences of the absence of dendritic cells
at different times during infection, and the dependence of system dynamics on the regulation of
lymphocyte exit from lymph nodes. In both cases, the model predicts the emergence of an impaired
immune response, i.e., the response is significantly reduced in magnitude. Dendritic cell removal is
also shown to delay the response time with respect to normal conditions.
Background
Lymph nodes and Peyer's patches play key roles in the
development of an appropriate and efficient immune
response. Once an Antigen (Ag) is captured by Ag-process-
ing cells, it is rapidly carried to the nearest lymph node,
where it is presented to specific lymphocytes to trigger an
immune response. The recognition phase must be highly
efficient: within a few hours, it is necessary to find specific
lymphocytes among a repertoire that includes a very large
number of receptors [1,2]. The specific architecture of the
lymph node and a fine-tuned balance between diffusion,
chemotaxis, and receptor expression are the basis of this
process.
Human lymph nodes are bean-shaped structures that
range in size from a few millimeters to about 1-2 cm in
their normal state. Internally, two main regions can be
distinguished: the medulla and the cortex. The cortex can
be further divided into an inner part, the paracortex (also
called the T cell area), rich in T lymphocytes and an outer
area, the node cortex that includes the B cell area consisting
of follicles and germinal centers, where B cells are acti-
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vated and differentiate [3]. T and B areas are identified by
high concentrations of different chemokines (CCR7 and
CXCR5, respectively) secreted by local stromal cells
[1,4,5]. The whole structure is supported by a dense net-
work of fibroblastic reticular cells that encloses small lym-
phatic channels of 10-15 μm in diameter along which
small molecules are thought to diffuse [6]. Macrophages,
dendritic cells (DC), and some lymphocytes flow from the
afferent lymphatic vessels, through the fibroblastic reticu-
lar cellular network, to the node cortex and the medulla,
before leaving via the efferent lymphatic vessels. Most T
and B cells, however, are too large in size and enter the
lymph node mainly from the blood, through high
endothelial venules (HEV) located inside the paracortex.
During an infection, lymphocyte recruitment from the
periphery is enhanced due to a widening of the primary
arteriole feeding the lymph node [2]. Once inside the
lymph node, B and T cells rapidly home in their own com-
partments, following a specific chemotactic gradient [1,4].
T helper cells (TH) are the fastest, with an average velocity
of 11 μm/min, followed by B cells with 6 μm/min and
DCs with a velocity of 3 μm/min [7].
In the absence of an antigenic challenge, T and B cells ran-
domly scan their respective areas for ~24-48 h before exit-
ing the lymph node [8]. Entrance of antigens into the
lymph node triggers a series of events leading to antigen
recognition and the activation of an immune response.
Two distinct pathways for antigen delivery have been rec-
ognized. In general, an Ag-presenting cell picks up the
antigen in peripheral tissues and migrates to the nearest
lymph node in order to present the MHC-peptide com-
plex to the T and B cells. In addition, antigens of low
molecular weight (below 70 kDa) may enter the lymph
node as soluble antigens and reach the T cell area directly
through the fibroblastic reticular cellular meshwork, with-
out any preliminary recognition. This delivery system is
very efficient, and soluble antigens are detected inside the
lymph node within a few minutes of infection. Here, spe-
cific resident DCs are able to capture the antigen well
before Ag-presenting cells arrive from peripheral organs
(on average, 8-12 h later) [9].
The immune response is initiated inside the T cell area,
where antigens are first presented to the T cells, generally
by DCs. After antigen recognition, peripheral dendritic
cells undergo a change in the expression of their surface
receptors. In particular, receptors for inflammatory chem-
okines are lost, and lymphoid receptors, especially the
CCR7 receptor, are expressed [10]. As a consequence, Ag-
presenting DCs are rapidly routed towards the T cell area,
where the probability of meeting specific T cells is higher.
In addition, once inside the lymph node, Ag-loaded DCs
begin to release specific chemokines (e.g., MDC) to guide
proximal active T cells [11,12].
B cell activation is initiated by an engagement of the B cell
receptor either by a soluble or a membrane-associated
antigen [13,14]. Following antigenic stimulation, B cells
start to co-express the CCR7 receptor [15,16] and rapidly
localize at the boundary between the T and B areas. Here,
they can receive the right costimulation by T helper cells
and start their proliferation and differentiation processes.
Unstimulated lymphocytes rapidly pass through the
lymph node to return to general circulation.
Lymphocyte egress from lymph nodes is still a subject of
investigation. Recent studies suggest a key role of the
Sphingosine-1-phosphate (S1P) molecule [17-19]. Its
specific receptor S1P1 acts as a type of "pass filter" that
selectively controls lymphocyte exit through efferent lym-
phatic vessels [19]. The receptor S1P1 is downregulated
during lymphocyte activation [17], preventing Ag-specific
lymphocytes from leaving the lymph node before an
immune response has been mounted.
The variety of mechanisms and the large number of enti-
ties present in a lymph node make it difficult to under-
stand the role played by each single component in the
overall behavior. Models for several different aspects of
lymphocyte motion have been developed [20-22]. Here,
we present a model of the lymph node that is able to cap-
ture the interplay between different mechanisms, and
which assures a fast and efficient immune response. We
focus on lymphocyte recruitment and trafficking inside
the lymph node, including specific cell diffusion proper-
ties, chemotaxis, and control of lymphocyte egress. We
resort to a hybrid discrete/continuous approach that com-
bines a stochastic agent-based description of cell interac-
tions with a continuous model of molecular diffusion
described by partial differential equations.
Agent-based models have a long history in immunology
[23-25] because they have proven to be well-suited to
handle complex nonlinearities and differences in individ-
ual cell characteristics. The choice of a hybrid approach is
motivated by the need to explicitly consider the effects of
chemotaxis on cells motility. This requires the introduc-
tion of a new timescale and, as a consequence, a distinct
level of representation with respect to the inter-cellular
interactions.
Methods
The model currently includes the description of three
types of cells: TH cells, B cells, and dendritic cells, plus
four chemokines, CXCR5, CCR7, S1P, and MDC.BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
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Cells are represented as discrete agents with specific char-
acteristics, that reside on a three-dimensional Cartesian
mesh (Fig. 1). Each set of cells is endowed with receptors
for antigen binding and one or more signaling receptors
that allow them to "sense" the concentration of specific
molecules. In addition, antigen-presenting cells, like B
cells and DCs, have one MHC class II receptor for antigen
processing (see Fig. 2). Receptors for antigen recognition
and processing are represented by binary strings that are
assigned randomly. On the other hand, the receptors for
the signaling molecules are described by Boolean varia-
bles (e.g., receptor ON means able to sense the corre-
sponding signal). Unlike antigen receptors, the expression
levels of these receptors can change during simulation,
depending on cell state.
Simple molecules like chemokines are represented by
their spatial concentration that acts as a signal that triggers
cellular interactions and movement. Unlike cells, mole-
cules are not endowed with an internal description.
Each cell entity is always characterized by one of four pos-
sible states: 1) active, meaning that the cell can perform
actions; 2) resting, meaning that the cell is waiting for the
activation signal; 3) presenting, that is, an antigen-pre-
senting cell exposes the antigen on the MHC class II mol-
ecule; 4) duplicating, meaning that the lymphocyte is in
the mitotic cycle (see Table 1).
Cells change their internal state when they interact with
other entities. Interactions are coded as probabilistic rules;
each interaction requires the cells involved to be in a spe-
cific state and the interaction probability depends on the
complementarity of their receptor strings, as measured by
their Hamming distance. The interactions are local and
many entities may sit on each single lattice site. In partic-
ular, for each lattice point, all interaction rules are exe-
cuted in random order and a greedy paradigm is applied
(i.e., cells that have interacted are taken out from the pool
for the current time step). The list of all included interac-
tions and signaling mechanisms is shown in Fig. 2.
The model description of chemotaxis is difficult due to the
range of timescales involved in the phenomenon. Cells, in
fact, are characterized by a diffusion coefficient much
lower than for small signaling molecules [26], that can
rapidly diffuse throughout the entire simulation volume.
The dynamics of molecules is considered deterministic,
ruled by a simple heat-like partial differential equation,
solved by an explicit finite difference scheme, describing a
uniform diffusion process, with the addition of a degrada-
tion term,
where  c  =  c(x) is the concentration of chemokines
(expressed in pM), D is the diffusion coefficient, and λ is
proportional to the half-life of the molecules. We assume
that D = 3000 μm2/min and λ = 3 h [25,26]. Homing
chemokines are continuously released by several sources
that are randomly distributed inside the T and B areas. At
each time step, a burst of new molecules is injected at each
source point and immediately spread by diffusion over
the simulation volume.
In contrast to chemokines, cells move individually at dis-
crete time steps (one simulation time step ~30 mins real
time). Chemotaxis is modeled in the following way. First,
we compute the normalized difference of chemoattractant
concentration between the current cell position and the
neighboring lattice points, yielding a set of discrete per-
centages of total neighboring chemoattractant. The prob-
∂
∂
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c
t
Dc
c 2
λ
,
Lymph node simulation mesh Figure 1
Lymph node simulation mesh. The three-dimensional ellipsoid lattice resembles the typical shape of a lymph node. The 
cube is a close-up of the volume unit where interactions between entities take place.BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
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Cells, their receptors, and the interactions among cells Figure 2
Cells, their receptors, and the interactions among cells. Panel (a) shows the cellular entities with their receptors: TCR 
and BCR are the antigen-receptors for the T and B lymphocytes, respectively; MDC, CCR7, and CXCR5 receptors are specific 
for the corresponding chemokines. S1P1 is the receptor for the molecule S1P that controls the exit of lymphocytes from the 
lymph node. In panel (b), connectors among the entities indicate that they interact.
B
BCR
CCR7
CXCR5
MHCII S1P1
TH
TCR
CCR7 MDC S1P1
DC
CCR7 MHCII
Ag
B
TH
DC
(a) (b)
Table 1: Cellular internal states. 
Entity States
Resting Active Presenting Duplicating
B ●❍ ❍
TH ●❍ ❍
DC ●❍
The behavior of cells is determined by their internal state because 
each interaction condition is defined in terms of eligible states. Circles 
imply that they can occupy that state. A full circle indicates the initial 
state of the cell.
Schematic representation of a lymph node internal architec- ture Figure 3
Schematic representation of a lymph node internal 
architecture. Schematic representation of the lymph node: 
T cell area (i.e., the paracortex) and a B cell area (i.e., the 
node cortex). A number of follicles are located in the node 
cortex, whereas the T cell area occupies the inner part. The 
medulla consists of a part of the T-area that allows cells to 
exit by the efferent vessel. T and B cells enter the lymph 
node mainly from the blood, through HEV located inside the 
paracortex (see text).BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
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ability of moving in each direction is then partitioned
according to the resulting percentages, and the direction
of cell displacement is chosen stochastically. This results
in cells moving with a higher frequency towards the max-
imum increase of chemoattractant concentration, and
with a lower frequency away from chemoattractants,
although this possibility is allowed. However, a minimal
intensity for the chemotactic gradient is required in order
to elicit a chemotactic response; a weak or null chemotac-
tic field results in a simple random walk, similar to the
one observed in two-photon microscopy imaging experi-
ments [27,28]. The threshold is assumed to be cell-
dependent. T cells are provided with a lower chemotactic
sensitivity than B and DC cells (of a factor 103) [1]. This
allows T cells to move essentially randomly inside their
area whereas B and dendritic cells are progressively guided
towards the appropriate position (respectively, the B cell
area and the T cell area) during the immune response
[3,29].
Differences in cell mobility are also taken into account.
Within the limit of our temporal resolution, the dynamics
of cell-cell interactions is not relevant, and cell velocity is
assumed to be constant during the entire simulation.
The transient effects of the chemotactic signals on a given
cell are modeled by a modulation in the expression of the
receptor signal, according to the cell's internal state. For
instance, when a B cell presents the antigen, the expres-
sion of its CXCR5 receptor is turned off, and the CCR7
receptor is expressed in its place. In this way, B cells are
redirected towards the boundary between the T and B cell
areas, to receive the appropriate costimulation.
An analogous description applies to the control of lym-
phocyte egress from the lymph node, modeled by a
change in the expression of the S1P receptor (i.e., the
S1P1). Once a lymphocyte is found at an exit site, its S1P1
status is checked and, if it is expressed (i.e., the receptor is
ON), the lymphocyte may leave the lymph node with a
Table 2: Parameter set - parameters of the simulation.
PARAMETER SYMBOL MEANING RANGE VALUE (UNITS) REF.
KNOWN VALUES
DupStepB dB B's duplication steps N 4[ 3 4 ]
DupStepTH dTH TH's duplication steps N 4[ 3 4 ]
VelocityB vB B cells' velocity R 6 μm/min [27,28]
VelocityTH vTH TH's velocity R 11 μm/min [27,28]
VelocityDC vDC DCs' velocity R 3 μm/min [25]
DiffCoeff D chemokines' diffusion coeff. R 3·103 μm2/min [27,28]
HalfLife λ chemokines' half life R 3 hrs [25,26]
NInitial [B] B(0) B's initials per μl N 105 (cells/μl) [5,31]
NInitial [TH] TH(0) TH's initials per μl N 2·105 (cells/μl) [5,31]
NInitial [DC] DC(0) DC's initials per μl N 103 (cells/μl) [5,31]
NCELLS_B_ENTRY fB incoming flux of TH cells N 31 cells/min [5]
NCELLS_TH_ENTRY fTH incoming flux of TH cells N 190 cells/min [5]
ARBITRARY PARAMETERS
NBITSTR l bit-string length N 22 (*) -
pDCAg pDC DC affinity to Ag (prob) [0, 1] 0.04 -
nHEV nHEV numbers of HEV per μl N 4 (μl-1)[ 3 0 ]
pExit pExit exit prob for cells [0, 1] 0.44 -
ChemQty q released chemokines qty R 108 mol (min src)-1 [35]
INITIAL CONDITIONS
microL mL volume N 10 (μl) -
deltaT Δt time resolution R 30 (min) -
nSteps T time steps of the simulation N 500 (steps) -
AgInjFreq fAg injection freq. of soluble Ags N 4 (day-1)-
AgInjQty nAg soluble Ags per injection N 100 -
Values that are taken from literature are provided with references. N and R indicate integer and real numbers respectively. (*) This choice of the bit 
string length represents a tradeoff between the computational cost of the simulation and the variability required for a realistic description of 
receptors repertoire.BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
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certain probability. When a TH or B cell succeeds in recog-
nizing the Ag, the S1P receptor is deactivated thus prevent-
ing the cell from leaving the lymph node. Only once
mature (i.e., after cloning), the lymphocyte's S1P receptor
is turned on again, and Ag-specific lymphocytes can
finally leave the lymph node. Exit control does not apply
to DCs which simply exit at a constant low rate [17]. We
use a three-dimensional mesh to model the typical ellip-
soid shape of a lymph node (Fig. 1). The simulated vol-
ume corresponds to the typical dimensions of a small
human lymph node (e.g., ~10 μl). Internally, this is mod-
eled as being composed of three regions: the T cell area
(i.e., the paracortex), the B cell area, consisting of a
number of follicles inside the node cortex, plus a region
(i.e., the medulla) that contains the exit gates (randomly
distributed) that lead to the efferent vessel (see Fig. 3). An
afferent vessel enters the node cortex from the top of the
simulation mesh.
The lattice unit is set equal to the average distance that a
TH cell (i.e., the fastest cell entity in the model [7]) covers
in one time step, i.e.,
where DTH is the diffusion coefficient for the TH cell and
Δt is the time step.
At each time step, a constant number of naïve TH and B
cells enter on the average the lymph node through several
high endothelial venules, randomly distributed inside the
T cell area [30]. Dendritic cells enter, instead, through the
lymphatic flux, from the afferent vessel. A continuous
renewal of lymphocytes and dendritic cells is provided by
assuming a total population of about 106 cells (fluxes
have been taken from [31]). To model the increase in lym-
phocyte recruitment during an infection, the incoming
flux of TH and B cells is augmented by a factor that is pro-
portional to the number of antigens inside the lymph
node. We represent antigens as small immunogenic mol-
ecules. The model includes the description of both mech-
anisms for antigen delivery, based on a passive or active
(i.e., DC-aided) transport mechanism. Soluble Ags are
introduced into the lymph node immediately after infec-
tion, at random sites inside the T compartment. DC-pre-
senting cells, instead, are inserted in the simulation
volume shortly after the injection of soluble Ags, approx-
imately 8-12 h later.
The parameters of the model can be classified into three
categories: 1) parameters that correspond to the initial
conditions of the system and that determine the problem
under investigation; 2) parameters whose values are well-
known and available from immunology literature; 3)
unknown values (free parameters) which we set after a
tuning procedure that starts with an initial guess based on
empirical rules and iteratively improves by looking at the
results of the simulations (see Table 2).
The tuning of free parameters was performed by compar-
ing the results against experimental values taken from the
literature. For instance, i) an average lymphocyte resi-
dence time inside the lymph node of approximately 24-48
h [8]; ii) an outgoing flux per day of 25% of the popula-
tion of cells [31]; (iii) an average homing time for newly-
arrived B lymphocytes of about 10 hrs (estimated from
[8]).
Results and Discussion
Lymph node function is characterized as being in one of
two distinct regimes or states, namely healthy or infected.
Each state, and the transition between states, is character-
ized by specific timescales that result from the delicate
combination of structural architecture, diffusion proper-
ties of components, and flux remodeling, as described
above. Our model succeeds in reproducing the expected
dynamics of the system with and without the presence of
antigenic stimulation.
In the absence of an infection, lymphocytes continuously
transit through lymph nodes during an endless surveil-
lance of bodily tissues for possible infection. Circulation
of the lymphocytes outside of the lymph nodes has been
estimated to require nearly 30 min [10]. Lymphocytes
spend approximately one day inside the lymph node
ΔΔ xD t TH ~, 6
Cell population dynamics in the absence of an antigenic stim- ulus Figure 4
Cell population dynamics in the absence of an anti-
genic stimulus. In the absence of an antigen challenge, the 
system remains in a steady state. The corresponding cell den-
sity agrees with the expected values given the volume of our 
simulation space.
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before leaving again [8]. This continuous flux assures a
constant renewal of the antigen expression repertoire and
increases the probability of recognizing the antigens. In
the absence of an infection, a balance between the incom-
ing and the outgoing flux must be achieved in order to
keep the cell population in a stable state. Fig. 4 shows the
total (Ag-specific and unspecific) number of cells in the
lymph node in the absence of antigenic challenge. Indeed,
the population reaches a constant value, and the corre-
sponding density agrees with the expected values, given
the simulated volume i.e., ~2·105 TH cells, 105 B cells and
103 DCs [5,31]. In particular, on average, 25-30% of TH
cells leave the lymph node in one day, whereas about 10%
of B cells are refreshed.
The arrival of Ags breaks the equilibrium, triggering a set
of well-balanced processes aimed at speeding antigen
presentation and immune system activation. Fig. 5 shows
the dynamics of the various cells populations in the pres-
ence of antigenic stimulus. Vertical bars in panel (D) show
the injection times for soluble antigens or DCs loaded
with antigen peptides. As soon as the first antigens reach
the lymph node, the lymphocyte density begins to
increase due to the strengthened incoming flux. Most anti-
gens are captured by DCs and B cells, as can be seen from
the sudden rise in the number of presenting cells. The
immune response initiates when antigen-specific lym-
phocytes start to duplicate. Fig. 6 shows the probability
distribution, obtained from 500 simulations, of TH and B
cell duplication as a function of time since Ag injection.
TH duplication is shown to initiate almost one day after
Ag injection, as reported by [5,32], whereas B cell
response, requiring costimulation, appears delayed. A
shift of about 24 h (see inset plot of the same figure) is evi-
dent between the B and TH responses, in reasonable
agreement with the experimental data that observed B cell
duplication ~ two days after infection [3,5].
As long as new antigens are detected, the immune
response persists: the total lymphocyte number increases
monotonically up to 5 times the original value [2,8], and
cells continue to duplicate, increasing the pool of availa-
ble Ag-specific cells (see Fig. 5). Once the infection is over,
the immune system and the lymph node recover the orig-
Simulation of an immune response during an infection Figure 5
Simulation of an immune response during an infection. The different panels show the dynamics of B cells, TH cells, and 
DCs (panels A, B, C, respectively), in the different states. Tot stands for total cell number, pres are the cells currently present-
ing the antigen at their surface, whereas the dup cells are the duplicating ones. Panel D shows the Ag concentration inside the 
lymph node, identifying the time window of infection. Vertical lines show the times of Ag and DC injection (inj Ag and inj DC, 
respectively).
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inal healthy state. After about 200 h, in the presented sim-
ulation, Ag concentration has nearly vanished, and the
incoming cell flux begins a decrease to its original value.
The total number of TH and B cells gradually reduces and
recovers its normal value within a couple of weeks. B cells
leave the lymph node at a lower rate because of their
reduced motility with respect to TH cells.
In silico experiments
We now use the model to investigate different scenarios
by perturbing the normal function of the system and look-
ing at the emergent response. Several experiments can be
designed in response to specific questions. In the follow-
ing, we propose two distinct experiments aimed at inves-
tigating the biological role of DC and S1P1-control of
lymphocyte egress on the onset of an efficient immune
response.
The role of dendritic cells
Dendritic cells are recognized as the most efficient anti-
gen-presenting cells. Their function is of primary impor-
tance for the activation of specific lymphocytes inside a
lymph node. In the following, we show the effect of
removing all DCs from the lymph node at a given time.
Depending on the delay from Ag injection, the effect on
the immune response varies.
Simulation results are showed in Fig. 7. When the DCs are
removed late in the simulation time, e.g., 20 h after Ag
injection, the immune system still has time to mount a
response. Both TH and B cell duplication are observable,
even if they appear reduced and slightly delayed with
respect to the unperturbed situation (see the dashed line
for comparison). If DCs are instead removed too early, the
immune response is completely shut off, because DCs do
not have enough time to activate TH cells. Only when
active, TH cells are able to stimulate B cells and to eventu-
ally duplicate, provided that the right signal is given.
Moreover, in an early DC removal, the few active THs are
unlikely to meet the specific B cells that fail to clone in the
absence of the essential costimulation. Therefore, in this
situation, the model predicts TH cell activation as a piv-
otal step in the onset of a correct immune response.
Lymphocyte exit control: role of the S1P receptor
The mechanisms that regulate lymphocyte exit from the
lymph node have been subject to intense research activity
in the last few years. Several studies implicate the Sphin-
gosine-1-phosphate receptor (S1P1) as a crucial element
for the regulation of the exit mechanism of lymphocytes
from the lymph node and highlight its importance in the
selective retention of Ag-specific lymphocytes during an
infection.
To investigate the impact on the overall adaptive immune
response, we block the S1P1 downexpression during TH
and B cell activation. As a result, all lymphocytes may
leave the lymph node once they reach an efferent vessel,
regardless of their antigen specificity. Fig. 8 compares the
average number of duplicating TH and B cells during an
immune response in the presence and absence of the S1P1
based mechanism described above. By blocking S1P1
downexpression, the magnitude of the immune response
is greatly reduced and the number of responding TH cells
is nearly halved. As a consequence, the number of anti-
bodies produced also decreases, thus weakening the
organism's protection against antigen infection.
However, the S1P1 control does not seem to affect the
onset and overall dynamics of the immune response: the
timing of lymphocyte encounters appears to be mainly
determined by the geometry and the diffusion properties
of the system rather than the Ag-specificity of its cell pop-
ulation.
Conclusion
We have developed a model that reproduces some aspects
of the immune response and the behavior of cell/antigen
motility within a lymph node. In particular, we focus on
the mechanisms that determine the onset of a primary
immune response, from Ag delivery to B cell activation
and duplication and the observed lymph node shrinking
after an immune response. We stress that the obtained T
and B cell responses at the correct times are emergent
properties of a quasi-realistic description of lymphocyte
density, interactions, and motion (including chemotaxis
and diffusion characteristics), combined with a schematic
Cell Duplication frequency during an immune response Figure 6
Cell Duplication frequency during an immune 
response. TH cells (continuous line) start cloning 24-30 hrs 
after Ag injection, whereas the B cell response (dashed line) 
is delayed by roughly one day, as reported in the literature. 
Results are obtained from 500 simulations.
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description of lymph node compartmentalization. This is
a key difference from previous work [5] in which the cor-
rect timing of the immune response was somehow hard-
coded in the simulator.
The model provides interesting insights into the role
played by DCs and by the regulation of lymphocyte exit
from lymph nodes on the resulting immune response. We
show an impaired immune response when one of these
mechanisms is perturbed. DC removal at early times pro-
duces large effects, with an immune response that is
greatly delayed and reduced in magnitude due to the lack
of active TH cells that are able to provide the right costim-
ulation of B lymphocytes. S1P1 control of specific cells,
instead, affects essentially the magnitude of the immune
response rather than the timing, by decreasing the overall
number of specific lymphocytes that can participate in Ag
detection. In the same spirit, many other experiments
could be planned to investigate, for example, the role of
chemotaxis and transient receptor expression on the dif-
ferent phases of Ag presentation.
The current model represents a first attempt to compre-
hensively sketch fundamental aspects of lymph node
In silico experiment: the role of DC cells Figure 7
In silico experiment: the role of DC cells. Number of Ag-specific duplicating lymphocytes after DC removal performed 5 
(inset plot) or 20 hrs after Ag injection. Results show the average number of duplicating TH (panel A) and B (panel B) cells. If 
DCs are removed too early, the immune response fails to mount.
In silico experiment: the role of lymphocyte exit control Figure 8
In silico experiment: the role of lymphocyte exit control. Number of Ag-specific duplicating lymphocytes with (dashed 
lines) and without (solid lines) S1P1 exit control. Results show the average number of duplicating TH (panel A) and B (panel B) 
cells. Blocking S1P1 downexpression, the magnitude of the immune response is greatly reduced.BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
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function based on a few cellular component and molecu-
lar mechanisms. Only essential pathways have been
included in the current version of the model, and further
work is needed to enhance the description of the rich vari-
ety of behaviors that can be observed in a real immune
response. Future improvements include a better descrip-
tion of B cell activation (by macrophages or dendritic
cells) and differentiation into plasma and memory cells.
In particular, it would be interesting to examine the
impact of T-independent B activation mechanisms on the
emergence of a humoral immune response [33]. Moreo-
ver, the presence of memory lymphocytes has important
consequences for the dynamics of a second immuniza-
tion. With the inclusion of memory cell generation in the
model, differences in lymphocyte population and Ag-
presentation efficiency between the primary and second-
ary responses could be analyzed. Specific Ag features (e.g.,
if it is a bacterium or a virus) and other related biological
processes could also be taken into account to address spe-
cific questions. In parallel with progress in lymph node
understanding, this simulator can be a useful tool to test
new hypotheses, investigating the effect of additional
mechanisms on the resulting immune response.
Availability and requirements
- Name: homing
- Home page: http://www.iac.cnr.it/~filippo/lymphn
ode.html
- Operating system(s): Unix/Linux, Windows, Mac OS
- Programming language: ANSI C
Authors' contributions
VB, FC, and MB conceived and designed the project; VB
developed the code; VB, PP and FC performed the simula-
tions and analyzed data; all authors wrote the paper.
Acknowledgements
We thank the "Consorzio interuniversitario per le Applicazioni di Supercal-
colo Per Università e Ricerca" (CASPUR) for computing resources and sup-
port. We also thank Mark Coles for useful and clarifying discussions. This 
work was partially supported by the European Community under the EC 
contract FP6-2004-IST-4, No.028069 (ImmunoGrid).
References
1. Cyster J: Chemokines and cell migration in secondary lym-
phoid organs.  Science 1999, 286:2098-2102.
2. Soderberg KA, Payne GW, Sato A, Medzhitov R, Segal SS, Iwasaki A:
Innate control of adaptive immunity via remodeling of
lymph node feed arteriole.  Proc Natl Acad Sci USA 2005,
102:16315-16320.
3. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK:
Visualization of Specific B and T Lymphocyte Interactions in
the Lymph Node.  Science 1998, 281(5373):96-99.
4. Moser B, Loetscher P: Lymphocyte traffic control by chemok-
ines.  Nat Immunol 2001, 2:123-128.
5. Catron DM, Itano AA, Pape KA, Mueller DL, Jenkins MK: Visualizing
the First 50 Hr of the Primary Immune Response to a Solu-
ble Antigen.  Immunity 2004, 21:341-347.
6. Willard-Mack CL: Normal structure, function, and histology of
lymph nodes.  Toxicol Pathol 2006, 34(5):409-24.
7. Miller MJ, Wei SH, Cahalan MD, Parker I: T cell repertoire scan-
ning is promoted by dynamic dendritic cell behavior and ran-
dom T cell motility in the lymph node.  Proc Natl Acad Sci USA
2004, 101:998-1003.
8. Qi H, Egen JG, Huang AYC, Germain RN: Extrafollicular Activa-
tion of Lymph Node B Cells by Antigen-Bearing Dendritic
Cells.  Science 2006, 312(5780):1672-1676.
9. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, Pabst
R, Lutz MB, Sorokin L: The Conduit System Transports Soluble
Antigens from the Afferent Lymph to Resident Dendritic
Cells in the T Cell Area of the Lymph Node.  Immunity 2005,
22:19-29.
10. von Andrian UH, Mempel TR: Homing and cellular traffic in
lymph nodes.  Nat Rev Immunol 2003, 3(11):867-878.
11. Katou F, Ohtani H, Nakayama T, Ono K, Matsushima K, Saaristo A,
Nagura H, Yoshie O, Motegi K: Macrophage-Derived Chemok-
ine (MDC/CCL22) and CCR4 Are Involved in the Formation
of T Lymphocyte-Dendritic Cell Clusters in Human Inflamed
Skin and Secondary Lymphoid Tissue.  Am J Pathol 2001,
158(4):1263-1270.
12. Kaiser A, Donnadieu E, Abastado JP, Trautmann A, Nardin A: CC
Chemokine Ligand 19 Secreted by Mature Dendritic Cells
Increases Naive T Cell Scanning Behavior and Their
Response to Rare Cognate Antigen.  J Immunol 2005,
175(4):2349-2356.
13. Bergtold A, Desai DD, Gavhane A, Clynes R: Cell Surface Recy-
cling of Internalized Antigen Permits Dendritic Cell Priming
of B Cells.  Immunity 2005, 23(5):503-514.
14. Okada T, Cyster J: B cell migration and interactions in the early
phase of antibody responses.  Curr Opin Immunol 2006,
18(3):278-285.
15. Reif K, Ekland E, Ohl L, Nakano H, Lipp M, Förster R, Cyster J: Bal-
anced responsiveness to chemoattractants from adjacent
zones determines B-cell position.  Nature 2002, 416:94-99.
16. Hardtke S, Ohl L, Forster R: Balanced expression of CXCR5 and
CCR7 on follicular T helper cells determines their transient
positioning to lymph node follicles and is essential for effi-
cient B-cell help.  Blood 2005, 106(6):1924-1931.
17. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V,
Allende ML, Proia RL, Cyster JG: Lymphocyte egress from thy-
mus and peripheral lymphoid organs is dependent on S1P
receptor 1.  Nature 2004, 427(6972):355-360.
18. Allende ML, Dreier JL, Mandala S, Proia RL: Expression of the
Sphingosine 1-Phosphate Receptor, S1P1, on T-cells Con-
trols Thymic Emigration.  J Biol Chem 2004,
279(15):15396-15401.
19. Wei SH, Rosen H, Matheu MP, Sanna GM, Wang SK, Jo E, Wong CH,
Parker I, Cahalan MD: Sphingosine 1-phosphate type 1 receptor
agonism inhibits transendothelial migration of medullary T
cells to lymphatic sinuses.  Nat Immunol 2005, 6(12):1228-1235.
20. Kesmir C, De Boer RJ: A Mathematical Model on Germinal
Center Kinetics and Termination.  J Immunol 1999,
163(5):2463-2469.
21. Kleinstein SH, Singh JP: Toward Quantitative Simulation of Ger-
minal Center Dynamics: Biological and Modeling Insights
from Experimental Validation.  J Theor Biol 2001, 211:253-275.
22. Beltman JB, Maree AF, de Boer RJ: Spatial modelling of brief and
long interactions between T cells and dendritic cells.  Immunol
Cell Biol 2007, 85:306-314.
23. Celada F, Seiden P: A computer model of cellular interaction in
the immune system.  Immunol Today 1992, 13:56-62.
24. Bernaschi M, Castiglione F: Design and implementation of an
immune system simulator.  Comput Biol Med 2001, 31:303-331.
25. Segovia-Juarez JL, Ganguli S, Kirschner D: Identifying control
mechanisms of granuloma formation during M. tuberculosis
infection using an agent-based model.  J Theor Biol 2004,
231(3):357-376.
26. Francis K, Palsson BO: Effective intercellular communication
distances are determined by the relative time constants for
cyto/chemokine secretion and diffusion.  Proc Natl Acad Sci USA
1997, 94(23):12258-12262.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Bioinformatics 2009, 10:387 http://www.biomedcentral.com/1471-2105/10/387
Page 11 of 11
(page number not for citation purposes)
27. Miller MJ, Wei SH, Parker I, Cahalan MD: Two-Photon Imaging of
Lymphocyte Motility and Antigen Response in Intact Lymph
Node.  Science 2002, 296(5574):1869-1873.
28. Miller MJ, Wei SH, Cahalan MD, Parker I: Autonomous T cell traf-
ficking examined in vivo with intravital two-photon micros-
copy.  Proc Natl Acad Sci USA 2003, 100:2604-2609.
29. Okada T, Miller M, Parker I, Krummel M, Neighbors Ma: Antigen-
Engaged B Cells Undergo Chemotaxis toward the T Zone
and Form Motile Conjugates with Helper T Cells.  Plos Biol
2005, 3(6):1047-1061.
30. Wei SH, Parker I, Miller MJ, Cahalan MD: A stochastic view of lym-
phocyte motility and trafficking within the lymph node.
Immunol Rev 2003, 195:136-159.
31. Young AJ: The physiology of lymphocyte migration through
the single lymph node in vivo.  Seminars in Immunology 1999,
11(2):73-83.
32. Mempel TR, Henrickson SE, Von Andrian UH: T-cell priming by
dendritic cells in lymph nodes occurs in three distinct phases.
Nature 2004, 427(6970):154-159.
33. Fagarasan S, Honjo T: T-Independent Immune Response: New
Aspects of B Cell Biology.  Science 2000, 290(5489):89-92.
34. Goldsby R, TJ TK, Osborne B: Kuby Immunology IV edition. New York:
W.H. Freeman and Company; 2003. 
35. Murray JD: Mathematical Biology Volume II. springer; 2003. 